Frank A. Greco

Carcinoma of unknown primary site

Frank A. Greco, Howard A. Burris, Joan B. Erland et al. · Cancer · 2000 · 84 citations

Medicine, Oncology, Radiation Oncology +17

Phloretin and phloretin analogs: Mode of action in planar lipid bilayers and monolayers

Juan G. Reyes, Frank A. Greco, R. Motais et al. · The Journal of Membrane Biology · 1983 · 66 citations

Natural Sciences, Biophysics, Pharmacology +14

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma

John D. Hainsworth, H.A. Burris, Frederic T. Billings et al. · Cancer · 2001 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

Combination Treatment with Weekly Docetaxel and Gemcitabine for Advanced Non–Small-Cell Lung Cancer in Elderly Patients and Patients with Poor Performance Status: Results of a Minnie Pearl Cancer Research Network Phase II Trial

John D. Hainsworth, Joan B. Erland, John H. Barton et al. · Clinical Lung Cancer · 2003 · 26 citations

Medicine, Oncology, Pharmacotherapy +13

The PI3K/mTOR inhibitor BEZ235 given twice daily for the treatment of patients (pts) with advanced solid tumors.

Hendrik‐Tobias Arkenau, Suzanne F. Jones, Carla Kurkjian et al. · Journal of Clinical Oncology · 2012 · 19 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +15